Final analysis of phase II trial of regorafenib (REG) in refractory advanced bil
- This topic has 0 replies, 1 voice, and was last updated 4 years, 11 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Final analysis of phase II trial of regorafenib (REG) in refractory advanced biliary cancers (BC).
http://abstracts.asco.org/239/AbstView_239_260011.html
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.